Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter
PHASE4
Patients hospitalized with paroxysmal atrial fibrillation and flutter to re...
Status
Completed
Location
Federal State Budgetary Institution NATIONAL MEDICAL RESEARCH CENTRE OF CARDIOLOGY NAMED AFTER ACADEMICIAN E.I.CHAZOV. of the Ministry of Health of the Russian Federation
Efficacy and Safety Evaluation of RefralonĀ®, Concentrate for Solution for Intravenous Injection in Patients With Paroxysmal and Persistent Atrial Fibrillation and Flutter
N/A
The goal of this retrospective registry is to evaluate the efficacy and saf...
Status
Completed
Location
Federal State Budgetary Educational Institution of Higher Education "Bashkir State Medical University" of the Ministry for Healthcare of the Russian Federation
A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug RefralonĀ®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form
PHASE2
RefralonĀ® tablets in two different doses (1 or 2 tablets per day) will be e...
Status
Active Not Recruiting
Location
National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Organization
Refralon in Patients With Recurrence Paroxysmal and Persistent Forms of Atrial Fibrillation Who Underwent Catheter Ablation
NA
It is planned to evaluate the efficacy and safety of the class III antiarrh...
Status
Completed
Location
Federal State Budgetary Institution NATIONAL MEDICAL RESEARCH CENTRE OF CARDIOLOGY NAMED AFTER ACADEMICIAN E.I.CHAZOV. of the Ministry of Health of the Russian Federation